Proliferation markers

Experimental and Toxicologic Pathology

Volumn 48, Issue 2-3, 1996, Pages 175-181

  Iatropoulos, Michael J ^a   Williams, Gary M ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

Cell proliferation; Markers, proliferation; Proliferation markers

Indexed keywords

GROWTH FACTOR;

ANIMAL CELL; ANIMAL MODEL; CELL CYCLE; CELL KINETICS; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG TOXICITY; HUMAN; HUMAN CELL; NONHUMAN; TUMOR SUPPRESSOR GENE;

ANIMALIA; RODENTIA;

EID: 0029874521     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0940-2993(96)80039-X     Document Type: Conference Paper

References (31)

1. BASERGA R, WEIBEL F: The cell cycle of mammalian cells. Int Rev Exp Pathol 1969; 7: 1-29.
2. BISCONTE JD: Kinetic analysis of cellular population by means of quantitative autoradiography. Int Rev Cytol 1970; 57: 76-126.
3. CLEAVER JE (ed.): Thymidine Metabolism and Cell Kinetics. North-Holland Publishing Co., Amsterdam 1967.
4. CROCKER J, NAR P: Nucleolar organizer regions in lymphomas. J Pathol 1987; 151: 111-118.
5. CUNNINGHAM JL, ELWELL MR, MATTHEWS HB: Relationship of carcinogenicity and cellular proliferation induced by mutagens. Fund Appl Toxicol 1994; 23: 363-369.
6. DIETRICH D: Toxicological and pathological applications of proliferating cell nuclear antigen (PCNA), a novel endogenous marker for cell proliferation. Crit Rev Toxicol 1993; 23: 77-109.
7. ELDRIDGE SR, TILBURY LF, GOLDSWORTHY TL, et al.: Measurement of chemically induced cell proliferation in rodent liver and kidney: a comparison of 5-bromo-2′deoxyuridine and [3H]thymidine administered by injection or osmotic pump. Carcinogenesis 1990; 11: 2245-2251.
8. GALAND P, DEGRAEF C: Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labeling for marking S phase cells in paraffin sections from animal and human tissues. Cell Tissue Kinet 1989; 22: 383-392.
9. GOLDSWORTHY TL, MORGAN KT, POPP JA, et al.: Guidelines for measuring chemically induced cell proliferation in specific rodent target organs. In: BUTTERWORTH BE (ed.): Chemically Induced Cell Proliferation: Implications for Risk Assessment. 1991; 253-284.
10. GRATZNER HG: Monoclonal antibody to 5-bromo-and 4-iododeoxyuridine: a new reagent for detection of DNA replication. Science 1982; 218: 474-475.
11. GRISHAM JW, KAUFMANN WK, KAUFMAN DG: The cell cycle and chemical carcinogenesis. Surv Snyth Path Res 1983; 1: 49-66.
12. HALL C, THAM P, MANANDHAR M, et al.: Assessment of in vivo clastosenicity and carcinogenicity. Toxicol Pathol 1988; 16: 10-21.
13. HEINISCH G, WOZEL G: Determination of epidermal proliferative activity in experimental mouse tail test by AgNOR analysis. Exp Toxic Pathol 1995; 47: 19-23.
14. HARD GC, IATROPOULOS MJ, THAKE DC, et at.: Identity and pathogenesis of stomach tumors in Sprague-Dawley rats associated with the dietary administration of Butachlor. Exp Toxic Pathol 1995; 47: 95-105.
15. IATROPOULOS MJ: Endocrine consideration in toxicologic pathology. Exp Toxic Pathol 1993/1994; 45: 391-410.
16. IATROPOULOS MJ, NEWMAN AJ, DAYAN AD, et al.: Urinary bladder hyperplasia in the rat: Non-specific pathogenetic considerations using a beta-lactam antibiotic. Exp Toxic Pathol 1994; 46: 265-274.
17. IATROPOULOS MJ: Comparative histokinetic and xenodynamic considerations in toxicity. In: WELLING PG, De La IGLESIA FA (eds.): Drug Toxicokinetics, Marcel Dekker Inc. New York 1993; 245-266.
18. KEY G, PETERSEN JL, BECKER MHG, et al.: New antiserum against ki-67 antigen suitable for double immunostaining of paraffin wax sections. J Clin Pathol 1993; 46: 1080-1084.
19. LAMERTON LF, STEEL GG: Cell population kinetics in normal and malignant tissues. Prog Biophys Mol Biol 1968; 18: 245-283.
20. LIPKIN M: The proliferative cycle of mammalian cells. In: BASERGA R (ed.): The Cell Cycle and Cancer. Marcel Dekker Inc. New York 1971; 1-25.
21. LARDELLI P, PERENTES E, MEIER G, et al.: Quantification of hepatocytic proliferation in the laboratory mouse. Exp Toxic Pathol 1994; 46: 95-100.
22. LIANG CM, DONEHOWER RC, CHABNER BA: Biochemical interactions between N-(phosphodiethyl)-L-aspartate and 5-fluorouracil. Molecular Pharmacol 1982; 21: 224-230.
23. MATHEWS DE, BATTEZZATI A: Substrate Kinetics and Catabolic Hormones. In: KINNEY JM, TUCKER HN (eds.): Organ Metabolism and Nutrition. Raven Press NY 1994; 1-22.
24. MONTICELLO TM, MORGAN KT, HURTT ME: Unit length as the denominator for quantitation of cell proliferation. Toxicol Pathol 1990; 18: 24-31.
25. NAKATSUJI S, YAMATI J, KUWAMURA M, et al.: Proliferating cell kinetics in healing following isoproterenol-induced myocardial injury. J Toxicol Pathol 1994; 7: 345-351.
26. PERENTES E, ARNOLD J, MEIER G, et al.: Proliferating Cell Nuclear antigen expression in Wistar rat Livers. Exp Toxic Pathol 1994; 46: 105-110.
27. PORTER-JORDAN K, LIPPMAN ME: Overview of the biological markers of breast cancer. Hematology Oncology Clinics for North America 1994; 8: 73-100.
28. SMITH ML, CHEN LT, ZHAN Q, et al.: Interaction of the p53-regulated protein Gadd 45 with proliferating cell nuclear antigen. Science 1994; 266: 1376-1380.
29. SWENBERG JA, BARROW CS, BOREIKO CJ, et al.: Non-linear biological responses to formaldehyde and their implication for carcinogenic risk assessment. Carcinogenesis 1983; 4: 945-952.
30. THAKE DC, IATROPOULOS MJ, HARD GC, et al.: A study of the mechanism of butachlor-associated gastric neoplasmas in Sprague-Dawley rats. Exp Toxic Pathol 1995; 47: 106-116.
31. WALDMAN FM, CARROLL PR, COHEN MB, et al.: 5-Bromodeoxyuridine incorporation and PCNA expression as measures of cell proliferation in transitional cell carcinoma of the urinary bladder. Modern Pathol 1993; 6: 20-24.